A nine-amino-acid neuropeptide and hormone studied across obstetrics, social neuroscience, pain modulation, and autonomic research.
Pre-loaded with a typical Oxytocin vial. Change any value to match what you actually have.
What published research and laboratory protocols actually document for Oxytocin. Where a compound has no single microgram figure, we say so rather than inventing one.
| Reported amount | Frequency | Route | Where this figure comes from |
|---|---|---|---|
| 4 mcg | single-dose experimental | subcutaneous | Experimental subcutaneous research (example peer-reviewed human SC study) A 2024 randomized-controlled trial used 4 mcg SC in healthy adults for heat-pain endpoints, an experimental dose, not a chronic protocol. |
| Not a fixed mcg value | study-defined (often single or limited repeated sessions) | intranasal | Common intranasal experimental neuroscience paradigms Many behavioral studies administer on the order of 24 IU intranasally; IU-to-mcg conversion depends on product labeling (about 1 IU ~ 1.67 mcg for oxytocin, confirm on label). |
| 10 mcg – 100 mcg | varies widely in informal sources | subcutaneous | Secondary research-peptide discussions of SC ranges (less standardized than obstetric IV/IM labeling) Informal mcg bands vary; prefer primary study methods over blog aggregates. Obstetric IV/IM regimens use IU on approved labels and are a separate clinical domain. |
People searching this page also look for: oxytocin peptide dosage chart, oxytocin peptide dosage for women, oxytocin peptide dosage protocol, oxytocin peptide dosage for men, oxytocin peptide dosage for men subcutaneous, oxytocin peptide dosage subcutaneous, oxytocin peptide 2mg dosage, oxytocin peptide injection dosage for women.
Oxytocin is an endogenous nonapeptide synthesized in the hypothalamus and released by the posterior pituitary. It is among the most thoroughly characterized peptides in human medicine because of long-standing obstetric uses, while a parallel research literature explores social cognition, stress responsivity, metabolic signals, and pain processing. Pharmacologically, oxytocin is notable for a very short plasma half-life after intravenous dosing, which is why obstetric protocols often rely on controlled infusions. Research outside obstetrics frequently uses intranasal delivery when central nervous system questions are in view; subcutaneous routes appear in selected experimental pain and animal studies. A 2024 randomized trial reported that a low microgram-range subcutaneous dose modulated heat-pain ratings in healthy adults, adding a peer-reviewed SC data point. Educational dosage content must separate approved obstetric regimens, intranasal social-neuroscience doses (often 24 IU in experimental paradigms), and research-peptide vial math. This page is research-and-education oriented with research-use-only framing for non-labeled contexts, not a guide for unsupervised hormone use.
Oxytocin binds the G protein-coupled oxytocin receptor (OXTR), expressed in uterus, mammary tissue, brain circuits, and peripheral sites. Receptor activation engages phospholipase C and calcium-dependent pathways that drive uterine smooth-muscle contraction and milk ejection in physiologic contexts. Centrally, OXTR signaling modulates social salience, anxiety-related circuits, and autonomic tone in experimental paradigms. Peripheral analgesic effects discussed in recent SC research may involve local receptor mechanisms in addition to any central actions.
obstetric pharmacology · social neuroscience · stress and affiliation biology · experimental pain modulation · metabolic and autonomic research
Obstetric clinical pharmacologists, affective and social neuroscientists, pain researchers, and endocrinology labs mapping OXTR distribution all work with oxytocin. Behavioral science groups dominate the intranasal literature. Peptide-education audiences often arrive via research-vial contexts and need help distinguishing IU obstetric dosing from mcg research vials.
Protect from heat and light; refrigerated storage is standard for oxytocin preparations. Reconstituted research solutions should be kept cold, tightly capped, and discarded per stability guidance. Oxytocin is oxidation- and temperature-sensitive relative to hardier lyophilized research peptides.
Neuroscience studies typically administer oxytocin alone when measuring social or stress endpoints. Combining with other neuropeptides confounds interpretation of OXTR-specific effects. Obstetric clinical protocols likewise do not stack research peptides; they follow labeled labor or postpartum pathways under medical supervision.
The questions people actually search for, answered plainly.
It depends entirely on context. Obstetric labeling uses IU for IV infusion or IM injection under clinical care. Social neuroscience often studies about 24 IU intranasally. A 2024 pain trial used 4 mcg subcutaneously as a single experimental dose. Research-vial mcg charts are not interchangeable with labor-and-delivery orders.
For a 10 mg research vial, even 2-3 mL produces a very concentrated solution relative to low-mcg experimental targets, so serial dilution may be required for accurate microgram dosing. Document every dilution step. Clinical products arrive with their own diluents and concentrations.
There is no general per-day research standard analogous to once-weekly incretins. Obstetric use is continuous or event-driven. Behavioral studies are usually session-based. Chronic daily SC schedules online should be treated skeptically without primary support.
Separate charts by route: IU for labeled obstetric products, IU for intranasal experimental sprays, and mcg for reconstituted research vials. Include the conversion note that product-specific IU-mcg relationships must be confirmed on the label.
IV obstetric effects on uterine tone can appear within minutes. Intranasal behavioral tasks are often timed 30-45 minutes after dosing in experimental protocols. SC analgesic endpoints in the 2024 trial were assessed in the post-injection experimental window defined by that study.
Plasma half-life after IV dosing is commonly summarized around 1-6 minutes (sometimes cited near 3-5 minutes), which is why infusions are used clinically. Intranasal and SC kinetics differ; central behavioral effects are not identical to plasma half-life.
Controlled research almost always isolates oxytocin when OXTR questions matter. Stacking with other neuroendocrine peptides muddies receptor-level inference. Clinical obstetric care follows dedicated protocols, not peptide stacks.
Convert vial mg to mcg (1 mg = 1,000 mcg), divide by diluent mL to get mcg/mL, then multiply by mL drawn. Because target experimental mcg amounts can be tiny, use adequate dilution and a precision syringe. Cross-check with a dosage calculator and a second person when preparing research aliquots.
Primary literature on Oxytocin. Open access where available.
Every citation above was programmatically checked against the NCBI PubMed database. Titles shown are the official indexed titles, not paraphrases.
Our support assistant walks through reconstitution, syringe units, storage, and how to read a Certificate of Analysis. Free, no account.
Read the guides